HCQ breakthrough: ICMR finds it’s effective in prevention of Covid 19
The Indian Council of Medical Research (ICMR), the country’s apex body in the field, has found that consuming the drug hydroxychloroquine reduces the chances of getting infected with Covid-19.
As a result, ICMR released an advisory Friday to expand the usage of HCQ — an anti-malarial drug — as a preventive treatment against the novel coronavirus.
Once again I refer to this lady’s opinions on herd immunity. She seems to have no investments in a vaccine (nothing to gain) but may have things to lose by coming out and stating her opinions. She is banned on YouTube but the BitChute link still works. She recommends HCQ as a “standby”, not as a preventative. Just build up your own immune system by using your own initiative to take action on your own to get some Vit C and D and Zinc. In other words, stand up and take care of yourself. Stop being led around like sheep.
The comments were interesting. I liked this on the most:
Ned May 15, 2020 at 1:07 pm
For those who are not prepared to forgo TV fake news for an hour and invest a hour for the planet, their families, their health and their freedom with truth…………Do not bother. you are probably a waste of space anyway.
Note: she uses charts from Chris Martenson’s video.
Wow, “Do not bother. you are probably a waste of space anyway” , quite an agressive statement: me don’t like.
People who know how to use orthomolecular are using vitamin C vitamin D and zinc. These orthomolecular experts explain how to do it.
Aggressive may be exactly what it takes. What choices do we the sheep have? How will this end? Does anyone ever think of these things? Try to get through this one without getting sick:
Thank you for the article.
Nice to see India is doing things correctly.
The advisory also states that the National Institute of Virology in Pune has found in laboratory testing that HCQ reduces the viral load.
The ICMR also analysed data collected previously, known as retrospective case-control analysis, and found “a significant” relationship between “the number of doses taken and frequency of occurrence of Covid-19 infection in symptomatic healthcare workers who were tested for SARS-CoV-2 infection”.
Based on the findings of the studies, the government has decided to administer the drug as a ‘prophylaxis’ or preventive therapy to asymptomatic healthcare workers working in non-Covid hospitals as well as non-Covid blocks of hospitals earmarked for Covid treatment.
Asymptomatic frontline workers, such as surveillance workers deployed in containment zones, as well as paramilitary and police personnel involved in Covid-related activities will be asked to pop HCQ pills.
[I like they even list side effect data, which to me seem mild compared to the benefits:]
However, in the final results of the studies (HCQ prophylaxis among 1,323 healthcare workers), the ICMR found mild adverse effects such as nausea in 8.9 per cent workers, abdominal pain in 7.3 per cent, vomiting in 1.5 per cent, low blood sugar (hypoglycaemia) in 1.7 per cent and cardio-vascular effects in 1.9 per cent.
Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir,
and Antibiotics for Moderate COVID-19: A First Report on the
Pharmacological Outcomes from South Korea
This first report on pharmacological management of COVID-19 from South
Korea revealed that HQ with antibiotics was associated with better clinical outcomes in terms of viral clearance, hospital stay, and cough symptom resolution compared to Lop/R with antibiotics or conservative treatment. The effect of Lop/R with antibiotics was not superior to conservative management. The adjunct use of the antibiotics may provide additional benefit in COVID-19 management but warrants further evaluation.